Summary
- Current Price
- As of today, RANI price is $1.10, up +13.41% in the most recent trading session on
- Current Price All-Time High
- RANI price is currently -96.98% below its historical high of $36.27 set on
- Market Cap
- RANI current market cap is $137M, up +458.11% over the past 365 days
- PE Ratio
- RANI PE ratio is unknown
- Revenue
- RANI current annual revenue is $1.63M, up +58.85% year-over-year
- Next Earnings
- The next earnings release for RANI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rani Therapeutics Holdings, Inc. |
| Ticker | NASDAQ: RANI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ranitherapeutics.com |
| Employees | 105 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.10 | ||
| Price, 1D Change | +13.41% | |
| $137M | ||
| - | ||
| - | ||
| 3.08 | ||
| $2M | ||
| Revenue, 1Y Change | +58.85% | |
| -$0.45 | ||
| EPS, 1Y Change | +57.45% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.45 | ||
| EPS Estimate | N/A | -$0.19 |
| EPS Est. Change | N/A | +56.75% |
| $1.63M | ||
| Revenue Estimate | N/A | $2.00M |
| Revenue Est. Change | N/A | +22.47% |
| $1.10 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +539.27% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.00 | -$1.05 | -5.42% | |
| -$0.44 | -$0.45 | -2.72% | |
| -$0.19 | N/A | +56.75% | |
| -$0.23 | N/A | +49.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.03M | - | |
| $5.19M | $1.63M | -68.51% | |
| $2.00M | N/A | +22.47% | |
| $9.01M | N/A | +451.75% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +50.00% | ||
| -72.07% | ||
| +458.11% | ||
| +37.50% | ||
| +58.85% | ||
| +100.00% | ||
| +57.45% | ||
| +65.07% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $1.10 | ||
| $1.12 | ||
| SMA 200 vs Price | +2.02% | |
| $1.03 | ||
| SMA 50 vs Price | -5.78% | |
| 3.08 | ||
| $0.08 | ||
| 52.62 | ||
| 73.65% | ||
| 276.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.63M | ||
| -$0.45 | ||
| $1.63M | ||
| 44.89% | ||
| -$38.31M | ||
| -2,345.99% | ||
| -$40.95M | ||
| -2,507.65% | ||
| -$37.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.13 | ||
| 4.21 | ||
| 4.21 | ||
| - | ||
| 5 | ||
| 0.33 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 83.76 | ||
| 4.14 | ||
| -2.44 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $33.01M | ||
| $49.71M | ||
| $58.62M | ||
| $53.32M | ||
| $17.11M | ||
| $12.67M | ||
| $4.32M | ||
| $1.59M | ||
| $309.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $31.31M | ||
| $39.94M | ||
| $900.00K | ||
| $0.00 | ||
| $900.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$18.71M | ||
| -$7.03M | ||
| $40.30M | ||
| $88.00K | ||
| -$18.80M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RANI
FAQ
What is the ticker symbol for Rani Therapeutics Holdings, Inc.?
The ticker symbol for Rani Therapeutics Holdings, Inc. is NASDAQ:RANI
Does Rani Therapeutics Holdings, Inc. pay dividends?
No, Rani Therapeutics Holdings, Inc. does not pay dividends
What sector is Rani Therapeutics Holdings, Inc. in?
Rani Therapeutics Holdings, Inc. is in the Healthcare sector
What industry is Rani Therapeutics Holdings, Inc. in?
Rani Therapeutics Holdings, Inc. is in the Biotechnology industry
What country is Rani Therapeutics Holdings, Inc. based in?
Rani Therapeutics Holdings, Inc. is headquartered in United States
When did Rani Therapeutics Holdings, Inc. go public?
Rani Therapeutics Holdings, Inc. initial public offering (IPO) was on July 30, 2021
Is Rani Therapeutics Holdings, Inc. in the S&P 500?
No, Rani Therapeutics Holdings, Inc. is not included in the S&P 500 index
Is Rani Therapeutics Holdings, Inc. in the NASDAQ 100?
No, Rani Therapeutics Holdings, Inc. is not included in the NASDAQ 100 index
Is Rani Therapeutics Holdings, Inc. in the Dow Jones?
No, Rani Therapeutics Holdings, Inc. is not included in the Dow Jones index
When was Rani Therapeutics Holdings, Inc. last earnings report?
Rani Therapeutics Holdings, Inc.'s most recent earnings report was on November 6, 2025
When does Rani Therapeutics Holdings, Inc. report earnings?
The next expected earnings date for Rani Therapeutics Holdings, Inc. is May 13, 2026
Data Sources & References
- RANI Official Website www.ranitherapeutics.com
- RANI Profile on Yahoo Finance finance.yahoo.com/quote/RANI
- RANI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rani